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Background: Monitoring public confidence and hesitancy is crucial for the COVID-19 vaccine rollout. Social media listening
(infoveillance) can not only monitor public attitudes on COVID-19 vaccines but also assess the dissemination of and public
engagement with these opinions.
Objective: This study aims to assess global hesitancy, confidence, and public engagement toward COVID-19 vaccination.
Methods: We collected posts mentioning the COVID-19 vaccine between June and July 2020 on Twitter from New York
(United States), London (United Kingdom), Mumbai (India), and Sao Paulo (Brazil), and Sina Weibo posts from Beijing (China).
In total, we manually coded 12,886 posts from the five global metropolises with high COVID-19 burdens, and after assessment,
7032 posts were included in the analysis. We manually double-coded these posts using a coding framework developed according
to the World Health Organization’s Confidence, Complacency, and Convenience model of vaccine hesitancy, and conducted
engagement analysis to investigate public communication about COVID-19 vaccines on social media.
Results: Among social media users, 36.4% (571/1568) in New York, 51.3% (738/1440) in London, 67.3% (144/214) in Sao
Paulo, 69.8% (726/1040) in Mumbai, and 76.8% (2128/2770) in Beijing indicated that they intended to accept a COVID-19
vaccination. With a high perceived risk of getting COVID-19, more tweeters in New York and London expressed a lack of
confidence in vaccine safety, distrust in governments and experts, and widespread misinformation or rumors. Tweeters from
Mumbai, Sao Paulo, and Beijing worried more about vaccine production and supply, whereas tweeters from New York and
London had more concerns about vaccine distribution and inequity. Negative tweets expressing lack of vaccine confidence and
misinformation or rumors had more followers and attracted more public engagement online.
Conclusions: COVID-19 vaccine hesitancy is prevalent worldwide, and negative tweets attract higher engagement on social
media. It is urgent to develop an effective vaccine campaign that boosts public confidence and addresses hesitancy for COVID-19
vaccine rollouts.
(J Med Internet Res 2021;23(6):e27632) doi: 10.2196/27632
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As of January 2021, the COVID-19 pandemic has led to more
than 100 million cases and 2 million deaths worldwide [1].
Although personal prevention measures such as mask wearing
and social distancing have been shown to be effective in curbing
the spread of COVID-19 [2], vaccination is expected to be the
key to the long-term prevention and control of the pandemic
[3,4]. The COVID-19 pandemic has triggered intense global
research and development (R&D) of vaccines against the
disease. Several candidate vaccines advanced to Phase III
clinical trials in mid-2020, including the Oxford/AstraZeneca,
Sinopharm, Sinovac, BioNTech/Pfizer, and Moderna vaccines,
and had finished clinical trials at the end of 2020. These vaccines
have been approved for use by December 2020 in some
countries such as the United Kingdom, the United States, and
China [5]. To ensure universal vaccination coverage,
governments must enhance public confidence, address the issue
of vaccine hesitancy, and design community engagement
strategies for COVID-19 vaccine rollouts.
Although immunization has proved successful in reducing the
global burden of illness and death, a range of concerns have
converged to affect public confidence in vaccines. When vaccine
confidence breaks down, hesitancy can cause serious
consequences such as delays, refusals, and disruptions to
research and delivery programs, and sometimes leads to the
resurgence of disease outbreaks [6]. Vaccine hesitancy has
proliferated over the decades and was cited by the World Health
Organization (WHO) as one of the top 10 global health threats
in 2019 [7,8]. Vaccine hesitancy is complex, multifactorial, and
influenced by a combination of emotional, cultural, social,
spiritual, and political factors. It can vary across countries,
vaccines, and time. Reports have indicated that hesitancy toward
general vaccines is prevalent among caregivers of children
worldwide, at rates such as 45.8% in France (2016) [7], 31.8%
in the United States (2014) [9], 24.6% in Italy (2017) [10], and
23% in Brazil (2016) [11]. The prevalence of vaccine hesitancy
among health care providers ranges from 2% to 16% across
different countries [12]. The accelerated R&D process of the
COVID-19 vaccine may further exacerbate public concern on
its safety and effectiveness [13]. Similarly, the novelty of the
disease, politicization of the vaccine, and distrust in experts and
governments have increased uncertainty about COVID-19
vaccination [3]. Therefore, it is necessary to assess public
confidence and acceptance toward the COVID-19 vaccine to
prepare for vaccine introduction.
Social media has become a source of data for detecting
outbreaks and understanding public attitudes and behaviors
during public health emergencies [14-16]. Large amounts of
real-time data posted on social media platforms can be used to
quickly identify public attitudes on COVID-19 vaccines as a
way to support health communication and health promotion
messaging. A growing body of literature has used social media
platforms such as Twitter and Facebook for public health
research [15]. Compared with traditional surveys, social media
listening can not only monitor public attitudes in a timely
manner but also assess the dissemination of and public
engagement with these opinions [17]. Individuals are
increasingly using social media to communicate with each other,
and public engagement can assess how various messages around
COVID-19 vaccines spread on social media. Although several
previous studies investigated public acceptance toward
COVID-19 vaccines using questionnaire surveys, it is unknown
how these opinions spread among the public.
By using social media listening data from the largest
metropolises worldwide, this study aimed to assess global
vaccine hesitancy and confidence toward COVID-19 vaccination




Twitter is one of the most popular social media platforms in the
world; Sina Weibo, Twitter in China, is the most influential
social media platform in China, with over 500 million users.
Users can share information or opinions by tweets or posts on
these platforms. Using the Meltwater platform [18], we collected
posts mentioning COVID-19 vaccines on Twitter from New
York (United States), London (United Kingdom), Mumbai
(India), Sao Paulo (Brazil), and Sina Weibo posts from Beijing
(China). The five metropolises were selected due to their high
disease burden of COVID-19. The data covered the period from
June 13 to July 31, 2020, when five COVID-19 vaccines started
their Phase III clinical trials worldwide, including the
Oxford/AstraZeneca, Sinopharm, Sinovac, BioNTech/Pfizer,
and Moderna vaccines [19]. The keywords included “COVID
vaccin*” OR “COVID-19 vaccin*” OR “COVID19 vaccin*”
OR “coronavirus vaccin*” OR “vaccin* for coronavirus” OR
“vaccin* for COVID.” Each post record comprised account
name, contents, post time, the number of followers, and
engagement data. Since our study aimed to assess public
attitudes toward COVID-19 vaccination, we only included
tweets or Weibo posts from individual accounts and excluded
those from news and organizational accounts. Duplicate tweets,
tweets with identical text but different tweet identifications,
retweets, quotes without comments, and irrelevant tweets were
removed [20]. This study was exempt from ethical review
because it examined retrospective publicly available data.
Content Analysis
We identified and classified posts describing personal opinions
or discussion of COVID-19 vaccines from Twitter and Sina
Weibo. A coding framework (Multimedia Appendix 1) was
developed for content analysis according to the WHO’s
Confidence, Complacency, and Convenience (“3 Cs”) model
of vaccine hesitancy [21] and validated through manual
annotation of the subset with 500 posts. All posts were
double-coded independently, and a third coder resolved
disagreements. Posts were initially classified as relevant or
irrelevant to personal opinions toward COVID-19 vaccines, and
relevant posts were further classified to the predefined categories
in Multimedia Appendix 1. Predefined categories included
attitudes toward COVID-19 vaccination (accept, neutral, doubt,
or refuse), expectations of COVID-19 vaccine R&D and
introduction (positive, neutral, or negative), confidence in
COVID-19 vaccine importance (important or not), confidence
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in COVID-19 vaccine effectiveness (effective or not),
confidence in COVID-19 vaccine safety (safe or not), trust in
governments (trust or not), trust in experts (trust or not),
misinformation or rumors about all vaccines, complacency
(perceived risk of getting COVID-19: high or low), COVID-19
vaccine convenience (accessibility, distribution, or affordability),
COVID-19 vaccine types (AstraZeneca, Moderna, Pfizer, or
Chinese vaccines), and others. Each post could be classified as
one category, multiple categories, or no category. We described
simple counts and percentages of posts for each topic on
COVID-19 vaccination.
Social Media Engagement Analysis
We also conducted social media engagement analysis to
investigate public communication and interaction about various
topics relating to the COVID-19 vaccine online. In Twitter, the
engagement metric measures all actions viewers have taken as
a result of seeing tweets and engaging with tweets [22]. At the
level of public engagement and interaction, Twitter engagement
refers to retweets, follows, replies, favorites, and clicks on the
tweets. It covers the three metrics of social media engagement:
popularity based on the number of likes for tweets, commitment
based on the number of comments for tweets, and virality based
on the number of shares for tweets [22]. The mean number and
SD of engagement with and followers of tweeters were presented
for each topic of COVID-19 vaccines.
Results
Description of Analyzed Social Media Posts
Figure 1 shows the process of data selection and analysis. In
total, we collected 12,886 social media posts mentioning a
COVID-19 vaccine. There were 3028 tweets on Twitter from
New York, 2672 tweets from London, 2166 tweets from
Mumbai, 396 tweets from Sao Paulo, and 4624 Sina Weibo
posts from Beijing. After assessment, 7032 posts met the
inclusion criteria and were included in our content analysis,
including 1568 tweets from New York, 1440 tweets from
London, 1040 tweets from Mumbai, 214 tweets from Sao Paulo,
and 2770 Sina Weibo posts from Beijing.
Figure 1. Flowchart of data process and analysis.
COVID-19 Vaccine Hesitancy and Confidence
Figure 2 presents social media users’ attitudes toward
COVID-19 vaccination. Among social media users, 36.4%
(571/1568) in New York and 51.3% (738/1440) in London
reported willingness to accept COVID-19 vaccines, much lower
than observed in metropolises in lower- and middle-income
countries (LMICs), such as 69.8% (726/1040) in Mumbai,
67.3% (144/214) in Sao Paulo, and 76.8% (2128/2770) in
Beijing. Although about 10% to 20% of users doubted the safety
or effectiveness of COVID-19 vaccines in each metropolis, 20%
(313/1568) in New York and 15.1% (218/1440) in London
expressed refusal, much higher than other metropolises (<5%),
leading to prevalent vaccine hesitancy. About 50% to 80% of
users discussed the R&D and introduction of the COVID-19
vaccine globally, with most showing positive expectations, and
the remaining users did not mention the R&D and introduction
of COVID-19 vaccines (Figure 3). The discussion levels on the
R&D and introduction of the COVID-19 vaccine in New York
and London were lower than those in Mumbai, Beijing, and
Sao Paulo.
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Figure 2. Social media users’ attitudes toward COVID-19 vaccination.
Figure 3. Expectations of COVID-19 vaccine R&D and introduction. R&D: research and development.
Table 1 conveys confidence, complacency, and convenience
related to COVID-19 vaccination on social media. Although
most tweets in each metropolis regarded COVID-19 vaccination
as important and effective, proportions of tweets perceiving
COVID-19 vaccines as unsafe in high-income countries (HICs;
133/1568, 8.5% in New York and 157/1440, 10.9% in London)
were much higher than those in other metropolises (<4%). These
HIC users expressed distrust in governments (>10%) and experts
(around 5%). Furthermore, 11.8% (185/1568) and 11%
(158/1440) of users in New York and London, respectively,
mentioned misinformation, rumors, or antivaccine campaigns,
but few users in LMIC metropolises (<7%) shared these
concerns.
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Table 1. Confidence, complacency, and convenience related to COVID-19 vaccines on social media in 2020.




Topics among relevant postsb, n (%)
Vaccine confidence
22 (10.3)140 (13.5)712 (25.7)130 (9.0)115 (7.3)Perceived importance of vaccines
22 (10.3)132 (12.7)651 (23.5)115 (8.0)96 (6.1)Important
0 (0.0)8 (0.8)61 (2.2)16 (1.1)19 (1.2)Unimportant
71 (33.2)294 (28.3)928 (33.5)361 (25.1)217 (13.8)Perceived effectiveness of vaccines
68 (31.8)261 (25.1)674 (24.3)305 (21.2)142 (9.1)Effective
3 (1.4)32 (3.1)254 (9.2)56 (3.9)75 (4.8)Ineffective
47 (22.0)190 (18.3)201 (7.3)354 (24.6)168 (10.7)Perceived safety of vaccines
43 (20.1)149 (14.3)143 (5.2)197 (13.7)35 (2.2)Safe
4 (1.9)41 (3.9)58 (2.1)157 (10.9)133 (8.5)Unsafe
8 (3.7)72 (6.9)148 (5.3)177 (12.3)294 (18.8)Trust in governments
1 (0.5)16 (1.5)138 (5.0)19 (1.3)14 (0.9)Trust
7 (3.3)56 (5.4)10 (0.4)158 (11.0)280 (17.9)Distrust
2 (0.9)78 (7.5)—c111 (7.7)90 (5.7)Trust in experts
2 (0.9)24 (2.3)—44 (3.1)14 (0.9)Trust
0 (0.0)54 (5.2)—67 (4.7)76 (4.8)Distrust
Information around vaccines
12 (5.6)30 (2.9)188 (6.8)158 (11.0)185 (11.8)Misinformation or rumors
Complacency
4 (1.9)45 (4.3)742 (26.8)52 (3.6)89 (5.7)Perceived risk of getting COVID-19
4 (1.9)41 (3.9)688 (24.8)45 (3.1)80 (5.1)High
0 (0.0)4 (0.4)54 (1.9)7 (0.5)9 (0.6)Low
Vaccine convenience
49 (22.9)99 (9.5)283 (10.2)76 (5.3)94 (6.0)Vaccine accessibility
26 (12.1)63 (6.1)325 (11.7)261 (18.1)309 (19.7)Vaccine distribution
20 (9.3)33 (3.2)197 (7.1)40 (2.8)107 (6.8)Vaccine affordability
122 (57.0)270 (26.0)941 (34.0)470 (32.6)259 (16.5)Vaccine types
63 (29.4)218 (21.0)82 (3.0)388 (26.9)102 (6.5)AstraZeneca
21 (9.8)31 (3.0)37 (1.3)30 (2.1)51 (3.3)Moderna
27 (12.6)18 (1.7)34 (1.2)26 (1.8)88 (5.6)Pfizer
13 (6.1)19 (1.8)831 (30.0)26 (1.8)25 (1.6)Chinese vaccines
5 (2.3)34 (3.3)990 (35.7)51 (3.5)83 (5.3)Others
aWe assessed 50% random samples from New York and London due to the large sample size, and full samples in Beijing, Mumbai, and Sao Paulo.
bTopics are calculated among relevant posts.
cTrust in experts is not measured specifically for Sina Weibo posts from Beijing.
Regarding complacency, most social media users perceived the
risk of getting COVID-19 to be high despite only a small number
of them (around 5% except Beijing) directly mentioning the
risk of getting COVID-19. For vaccination convenience,
approximately 5% of HIC users mentioned vaccine accessibility,
whereas more users in LMIC metropolises (10%-20%) worried
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about vaccine accessibility, including production and supply
capacity for COVID-19 vaccines. Nearly 20% of HIC users
worried about vaccine distribution, including priority vaccination
groups, whereas less users in LMIC metropolises (around 10%)
mentioned this subject. Few users (about 5%) considered vaccine
affordability in mid-2020. There were differential concerns on
vaccine accessibility worldwide.
The proportion of tweets mentioning specific vaccine types was
16.5% (259/1568) in New York, 57% (122/214) in Sao Paulo,
and around 30% in the remaining three metropolises. Tweets
in New York mainly discussed COVID-19 vaccines produced
in the United States, and tweets in other metropolises discussed
vaccines produced worldwide. In terms of specific COVID-19
vaccines that had started Phase III clinical trials, social media
users in metropolises except for Beijing mostly mentioned the
Oxford/AstraZeneca vaccine, followed by the BioNTech/Pfizer
and Moderna vaccines; the Chinese vaccine was the least
frequently mentioned. This indicated that public attention was
consistent to the development progress of specific vaccines.
Engagement Levels of COVID-19 Vaccine–Related
Tweets
Table 2 presents the engagement metrics of COVID-19
vaccine–related tweets by topic. On average, tweeters who
posted COVID-19 vaccine–related tweets had 3634 followers,
and their followers ranged from 1637 (expressing COVID-19
vaccination is important) to 4778 followers (expressing
COVID-19 vaccination is unsafe) and 7430 followers
(expressing COVID-19 vaccination is ineffective). Overall,
tweeters expressing negative attitudes toward COVID-19
vaccines, such as doubt or refusal to vaccinate, lack of
confidence in vaccines (importance, effectiveness, and safety),
and misinformation or rumors, had more followers than those
expressing positive attitudes.
COVID-19 vaccine–related tweets attracted 6.1 engagement
values on average. When comparing engagement levels on
different topics regarding COVID-19 vaccines, we found that
the most active topics were misinformation (engagement value
14.0), followed by confidence in vaccine safety (13.1), vaccine
effectiveness (10.9), and governments (9.7), whereas the least
active topics were vaccine convenience (2.6-5.8), confidence
in vaccine importance (3.6) and experts (3.8), and complacency
(5.4). For topics on vaccine hesitancy and expectations in
vaccine R&D and introduction, tweets with clear attitudes
attracted more engagement than neutral tweets, but there was
little difference in public engagement between tweets with
positive and negative attitudes. For each topic regarding vaccine
confidence except distrust in governments, lack of confidence
propagated more than having confidence, especially for vaccine
safety (16.7 engagement for tweets expressing vaccine is unsafe
vs 10.3 engagement for tweets expressing vaccine is safe); trust
in governments attracted much more engagement than distrust
(52.8 vs 5.4), representing the public’s common expectations
of governments taking an active role in controlling the epidemic.
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Table 2. Followers and engagements of COVID-19 vaccine–related tweets in 2020.
Engagements, mean (SD)Followers, mean (SD)Topics
Vaccine hesitancy










3.6 (10.7)1763.6 (3727.9)Perceived importance of vaccines
3.4 (9.9)1636.5 (3167.2)Important
5.4 (16.5)2843.1 (6811.7)Unimportant
10.9 (115.5)3373.4 (13,960.7)Perceived effectiveness of vaccines
10.6 (119.5)2505.6 (8366.8)Effective
12.2 (94.7)7430.1 (27,615.6)Ineffective
13.1 (137.2)3274.3 (14,058.0)Perceived safety of vaccines
10.3 (137.4)2086.2 (6191.7)Safe
16.7 (137.1)4778.0 (19,897.0)Unsafe
9.7 (111.8)3865.2 (16,363.8)Trust in governments
52.8 (360.4)3055.6 (6573.5)Trust
5.4 (28.7)3946.0 (17,036.6)Distrust




14.0 (121.2)3127.7 (11,610.5)Misinformation or rumors
Vaccine complacency




2.6 (7.8)2351.5 (8915.4)Vaccine accessibility
5.8 (26.2)3531.5 (12,541.6)Vaccine distribution
3.1 (8.3)2525.3 (4895.6)Vaccine affordability
aR&D: research and development.
Discussion
Principal Findings
This social listening study in large metropolitan areas in five
countries examined hesitancy toward COVID-19 vaccination;
perceptions of vaccine confidence, complacency, and
convenience; and level of online public engagement. We found
that COVID-19 vaccine hesitancy was prevalent worldwide,
with the highest prevalence in New York and London, followed
by Sao Paulo and Mumbai, and the lowest in Beijing. With high
perceived risk of getting COVID-19, social media users in HICs,
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including the United States and the United Kingdom, expressed
low acceptance of COVID-19 vaccines, serious concerns
regarding vaccine safety, and distrust in governments and
experts. There were different concerns about vaccination
convenience and accessibility between HICs and LMICs.
Negative tweets expressing lack of vaccine confidence and
misinformation or rumors had more followers and attracted
more online public engagement.
Overall, social media users expressed relatively high hesitancy
toward COVID-19 vaccination across metropolises with high
COVID-19 burdens. There were no metropolises where
willingness to accept a COVID-19 vaccine exceeded 80%, and
only between 36% to 50% of tweeters accepted the COVID-19
vaccine especially in New York and London. These social
listening results were similar to global survey studies [13,23],
which showed that COVID-19 vaccine acceptance was higher
in China, India, and Brazil but lower in the United States and
the United Kingdom. Over the past decade, vaccine refusal has
accelerated worldwide, and antivaccine activities have been
amplified through political activities and social media [24]. The
prevalent hesitancy toward COVID-19 vaccines could
potentially lead to low vaccination coverage, which will further
delay global control of the pandemic and societal and economic
recovery. Recent studies estimated a COVID-19 R0 of around
3.87 for Europe and around 3.45 for the United States [25,26],
implying herd immunity thresholds of 74% and 71%,
respectively. The current acceptance levels among tweeters in
New York, London, Mumbai, and Sao Paulo is insufficient to
reach this 71% to 74% threshold; one exception is Beijing with
an acceptance level at 76.8%. As governments are preparing to
introduce COVID-19 vaccines and initiate postpandemic
recovery, the need to develop an effective vaccine campaign
for the rollout that boosts public confidence and addresses
hesitancy is urgent.
A previous study showed that confidence in vaccines and
governments was strongly associated with vaccine acceptance
and uptake [13]. However, our findings showed lack of
confidence in vaccine safety, distrust in governments and
experts, and widespread misinformation or rumors, especially
in HICs. Public confidence in the safety and effectiveness of
COVID-19 vaccines was far lower than the confidence level in
general vaccines. In the 2018 Global Monitor Survey, 79% and
84% of the public agreed that vaccines were safe and effective
globally [27]. During COVID-19, the development of a vaccine
for a new pathogen has been pushed much faster than ever
before, and new bioscience technologies (eg, mRNA vaccine)
are being used in humans for the first time [5,28]. In light of
the accelerated R&D process, any negative news related to
vaccine failure may weaken public confidence in its safety and
effectiveness [13,29]. Therefore, effective communication
campaigns should be designed to explain the safety of
COVID-19 vaccines to the public and clarify misinformation
or rumors, especially in HICs. Communication campaigns
should be supported by the scientific community to address
public concerns in COVID-19 vaccines. Through creating a
space for a collaborative dialogue between the scientific
community and the public, these campaigns would aim to not
only provide the public with the latest information but also build
public confidence in vaccine programs.
Social media users in HICs and LMICs expressed different
concerns about vaccination convenience and accessibility. HIC
users had less concerns about production and supply capacity
of COVID-19 vaccines but more concerns on vaccine
distribution and inequity. In contrast, LMIC users worried more
about vaccine production and supply instead of vaccine
distribution. Although HICs can ensure the supply of COVID-19
vaccines, systemic racial and economic disparities have existed
for a long time in many fields, including health care and
vaccination. The COVID-19 pandemic has disproportionately
affected low-income groups and communities of color [24].
Disparities in access to COVID-19 vaccines possibly still occur
and may be a point of concern that needs to be addressed in
HICs. There is also much concern regarding access to
COVID-19 vaccines and rollout gaps in LMICs compared with
HICs. Many HICs have sought to gain priority access to
COVID-19 vaccines by striking advance purchase agreements
with vaccine manufacturers, instead of through WHO’s global
allocation mechanism, leaving few vaccine doses for LMICs
[23,30]. Therefore, vaccine campaigns should be tailored to
each context to address local concerns: LMICs should take
efforts to address vaccine supply issues and HICs should focus
more on equitable distribution within countries. This study calls
for strengthened international partnerships and coordination to
address the equitable access to COVID-19 vaccines worldwide,
and the WHO should be empowered to take a leading role in
guiding more preparedness actions to control the epidemic [31].
According to social media engagement analysis, we found that
negative tweets had more followers and higher engagement than
positive tweets. This finding might demonstrate that users on
Twitter are more interested in communicating and disseminating
negative messages such as those expressing misinformation or
rumors and lack of vaccine confidence. Previous studies showed
that Twitter users sharing misinformation tend to be more
connected and clustered [32], and false information travels faster
than true information does in social networks [33]. Although
scientific experts received considerable attention early on in the
COVID-19 pandemic, online attention shifted toward political
communities as the pandemic developed [34]. During the
evolution of the pandemic, scientific experts lost some of their
influence, and it became harder for scientific information to
reach a broad audience. In addition, the spread of misinformation
or rumors on social media has been found to be significantly
associated with vaccine hesitancy [35]. Social media is therefore
a double-edged sword that not only can help disseminate public
health knowledge directly to the public but also that can, through
inappropriate use, be destructive to public health efforts,
especially during a public health emergency [36-38]. Therefore,
more efforts are needed to build a more proactive public health
presence on social media, and health systems should listen to
tweets from the public to help inform policies related to public
health response.
Limitations
This study captured routine populations who may not be
represented in traditional research designs, and social media
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data can eliminate reporting bias that occurs from speaking with
a researcher [20]. However, this study has some limitations.
First, there is an inherent bias shared among all social media
studies, where users might present themselves differently online
or represent a skewed-younger population [39]. Second, we did
not extract demographic data because of difficulty to refer to
users’ profiles. Third, we used manual coding methods rather
than automated annotation, which increased the length of time
taken to annotate. Therefore, we only assessed vaccine hesitancy
in large metropolises in a short period, and it reduced the
generalizability of our findings. In the future, based on our
coding data set from this study, we plan to develop a machine
learning program to continuously track public attitudes toward
COVID-19 vaccination.
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